JP2013503643A5

JP2013503643A5 -

Download PDF

Info

Publication number: JP2013503643A5
Authority: JP; Japan
Prior art keywords: subtype; genes; certain embodiments; protein; combination
Prior art date: 2010-09-02
Legal status : Granted

Application number

JP2012528063A

Other languages

English (en)

Japanese (ja)

Other versions

JP5996429B2 (ja

JP2013503643A (ja

Filing date

2010-09-02

Publication date

2014-05-22

2010-09-02 Application filed filed Critical

2010-09-02 Priority claimed from PCT/US2010/047734 external-priority patent/WO2011028945A1/en

2013-02-04 Publication of JP2013503643A publication Critical patent/JP2013503643A/ja

2014-05-22 Publication of JP2013503643A5 publication Critical patent/JP2013503643A5/ja

2016-06-23 Priority to JP2016124696A priority Critical patent/JP6895718B2/ja

2016-09-21 Application granted granted Critical

2016-09-21 Publication of JP5996429B2 publication Critical patent/JP5996429B2/ja

Status Active legal-status Critical Current

2030-09-02 Anticipated expiration legal-status Critical

Links

108090000623 proteins and genes Proteins 0.000 claims description 690
102000004169 proteins and genes Human genes 0.000 claims description 291
230000014509 gene expression Effects 0.000 claims description 189
238000000034 method Methods 0.000 claims description 143
101000858064 Homo sapiens C-X-C motif chemokine 13 Proteins 0.000 claims description 81
102100025277 C-X-C motif chemokine 13 Human genes 0.000 claims description 79
102100031507 Fc receptor-like protein 5 Human genes 0.000 claims description 48
101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims description 48
101000666295 Homo sapiens X-box-binding protein 1 Proteins 0.000 claims description 26
239000012472 biological sample Substances 0.000 claims description 24
102100038151 X-box-binding protein 1 Human genes 0.000 claims description 23
102100027207 CD27 antigen Human genes 0.000 claims description 19
101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 19
108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 claims description 18
102100037871 Intercellular adhesion molecule 3 Human genes 0.000 claims description 18
102000003810 Interleukin-18 Human genes 0.000 claims description 18
108090000171 Interleukin-18 Proteins 0.000 claims description 18
108010004684 Pituitary adenylate cyclase-activating polypeptide Proteins 0.000 claims description 18
102000002808 Pituitary adenylate cyclase-activating polypeptide Human genes 0.000 claims description 18
206010039073 rheumatoid arthritis Diseases 0.000 description 290
235000018102 proteins Nutrition 0.000 description 276
239000000523 sample Substances 0.000 description 186
230000002068 genetic effect Effects 0.000 description 126
210000003719 b-lymphocyte Anatomy 0.000 description 106
210000002966 serum Anatomy 0.000 description 95
238000011282 treatment Methods 0.000 description 76
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 67
239000003814 drug Substances 0.000 description 66
230000001225 therapeutic effect Effects 0.000 description 63
201000010099 disease Diseases 0.000 description 61
239000005557 antagonist Substances 0.000 description 58
206010003246 arthritis Diseases 0.000 description 57
239000000090 biomarker Substances 0.000 description 57
102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 56
230000027455 binding Effects 0.000 description 54
210000004027 cell Anatomy 0.000 description 50
241000219061 Rheum Species 0.000 description 46
108090000765 processed proteins & peptides Proteins 0.000 description 45
102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 43
102000004196 processed proteins & peptides Human genes 0.000 description 42
101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 41
210000001519 tissue Anatomy 0.000 description 41
230000004044 response Effects 0.000 description 39
229920001184 polypeptide Polymers 0.000 description 37
229960004641 rituximab Drugs 0.000 description 35
230000006378 damage Effects 0.000 description 31
229940079593 drug Drugs 0.000 description 31
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 30
239000000427 antigen Substances 0.000 description 30
108091007433 antigens Proteins 0.000 description 30
102000036639 antigens Human genes 0.000 description 30
229960000485 methotrexate Drugs 0.000 description 30
238000011532 immunohistochemical staining Methods 0.000 description 29
150000007523 nucleic acids Chemical class 0.000 description 29
239000000203 mixture Substances 0.000 description 28
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 27
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 27
230000000875 corresponding effect Effects 0.000 description 26
102000039446 nucleic acids Human genes 0.000 description 26
108020004707 nucleic acids Proteins 0.000 description 26
229940068196 placebo Drugs 0.000 description 26
239000000902 placebo Substances 0.000 description 26
210000001503 joint Anatomy 0.000 description 25
229940124597 therapeutic agent Drugs 0.000 description 25
238000002493 microarray Methods 0.000 description 24
-1 TGF2 Proteins 0.000 description 23
230000000694 effects Effects 0.000 description 22
229960000598 infliximab Drugs 0.000 description 21
238000012360 testing method Methods 0.000 description 20
108060008682 Tumor Necrosis Factor Proteins 0.000 description 19
230000006870 function Effects 0.000 description 19
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 18
238000003745 diagnosis Methods 0.000 description 18
108091033319 polynucleotide Proteins 0.000 description 18
102000040430 polynucleotide Human genes 0.000 description 18
239000002157 polynucleotide Substances 0.000 description 18
101000998176 Homo sapiens Interleukin-17D Proteins 0.000 description 17
238000003556 assay Methods 0.000 description 17
230000001965 increasing effect Effects 0.000 description 17
102100033096 Interleukin-17D Human genes 0.000 description 16
238000004458 analytical method Methods 0.000 description 16
239000002771 cell marker Substances 0.000 description 16
108010087819 Fc receptors Proteins 0.000 description 15
102000009109 Fc receptors Human genes 0.000 description 15
101001078151 Homo sapiens Integrin alpha-11 Proteins 0.000 description 15
101000599852 Homo sapiens Intercellular adhesion molecule 1 Proteins 0.000 description 15
101001095308 Homo sapiens Periostin Proteins 0.000 description 15
102100037765 Periostin Human genes 0.000 description 15
210000001744 T-lymphocyte Anatomy 0.000 description 15
108010065323 Tumor Necrosis Factor Ligand Superfamily Member 13 Proteins 0.000 description 15
210000000265 leukocyte Anatomy 0.000 description 15
239000003550 marker Substances 0.000 description 15
125000003729 nucleotide group Chemical group 0.000 description 15
238000002601 radiography Methods 0.000 description 15
102100038080 B-cell receptor CD22 Human genes 0.000 description 14
101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 14
102100025320 Integrin alpha-11 Human genes 0.000 description 14
102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 14
102100026261 Metalloproteinase inhibitor 3 Human genes 0.000 description 14
108010031429 Tissue Inhibitor of Metalloproteinase-3 Proteins 0.000 description 14
102100039037 Vascular endothelial growth factor A Human genes 0.000 description 14
125000003275 alpha amino acid group Chemical group 0.000 description 14
230000008859 change Effects 0.000 description 14
239000013610 patient sample Substances 0.000 description 14
102000005962 receptors Human genes 0.000 description 14
108020003175 receptors Proteins 0.000 description 14
210000005222 synovial tissue Anatomy 0.000 description 14
108091007507 ADAM12 Proteins 0.000 description 13
208000023275 Autoimmune disease Diseases 0.000 description 13
101800001382 Betacellulin Proteins 0.000 description 13
102100021943 C-C motif chemokine 2 Human genes 0.000 description 13
108010074051 C-Reactive Protein Proteins 0.000 description 13
102100036189 C-X-C motif chemokine 3 Human genes 0.000 description 13
102100032752 C-reactive protein Human genes 0.000 description 13
102100039551 Collagen triple helix repeat-containing protein 1 Human genes 0.000 description 13
102100038493 Cytokine receptor-like factor 1 Human genes 0.000 description 13
102100031112 Disintegrin and metalloproteinase domain-containing protein 12 Human genes 0.000 description 13
108010008165 Etanercept Proteins 0.000 description 13
102100025783 Glutamyl aminopeptidase Human genes 0.000 description 13
101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 description 13
101000947193 Homo sapiens C-X-C motif chemokine 3 Proteins 0.000 description 13
101000746121 Homo sapiens Collagen triple helix repeat-containing protein 1 Proteins 0.000 description 13
101000956431 Homo sapiens Cytokine receptor-like factor 1 Proteins 0.000 description 13
101000719019 Homo sapiens Glutamyl aminopeptidase Proteins 0.000 description 13
108090001007 Interleukin-8 Proteins 0.000 description 13
102000004890 Interleukin-8 Human genes 0.000 description 13
102100029837 Probetacellulin Human genes 0.000 description 13
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 13
230000006872 improvement Effects 0.000 description 13
230000002829 reductive effect Effects 0.000 description 13
208000024891 symptom Diseases 0.000 description 13
102100034608 Angiopoietin-2 Human genes 0.000 description 12
102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 12
102100021633 Cathepsin B Human genes 0.000 description 12
102100024940 Cathepsin K Human genes 0.000 description 12
102100027995 Collagenase 3 Human genes 0.000 description 12
102100022825 Disintegrin and metalloproteinase domain-containing protein 22 Human genes 0.000 description 12
102100024364 Disintegrin and metalloproteinase domain-containing protein 8 Human genes 0.000 description 12
102100028412 Fibroblast growth factor 10 Human genes 0.000 description 12
102100035290 Fibroblast growth factor 13 Human genes 0.000 description 12
102100035323 Fibroblast growth factor 18 Human genes 0.000 description 12
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 12
102100021261 Frizzled-10 Human genes 0.000 description 12
102100039676 Frizzled-7 Human genes 0.000 description 12
102100028466 Frizzled-8 Human genes 0.000 description 12
101000924533 Homo sapiens Angiopoietin-2 Proteins 0.000 description 12
101000899390 Homo sapiens Bone morphogenetic protein 6 Proteins 0.000 description 12
101000898449 Homo sapiens Cathepsin B Proteins 0.000 description 12
101000761509 Homo sapiens Cathepsin K Proteins 0.000 description 12
101000577887 Homo sapiens Collagenase 3 Proteins 0.000 description 12
101000756722 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 22 Proteins 0.000 description 12
101000832767 Homo sapiens Disintegrin and metalloproteinase domain-containing protein 8 Proteins 0.000 description 12
101000917237 Homo sapiens Fibroblast growth factor 10 Proteins 0.000 description 12
101000878128 Homo sapiens Fibroblast growth factor 18 Proteins 0.000 description 12
101000819451 Homo sapiens Frizzled-10 Proteins 0.000 description 12
101000885797 Homo sapiens Frizzled-7 Proteins 0.000 description 12
101001061408 Homo sapiens Frizzled-8 Proteins 0.000 description 12
101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 12
101001019591 Homo sapiens Interleukin-18-binding protein Proteins 0.000 description 12
101001039199 Homo sapiens Low-density lipoprotein receptor-related protein 6 Proteins 0.000 description 12
101000577881 Homo sapiens Macrophage metalloelastase Proteins 0.000 description 12
101001011886 Homo sapiens Matrix metalloproteinase-16 Proteins 0.000 description 12
101000627861 Homo sapiens Matrix metalloproteinase-28 Proteins 0.000 description 12
101000653788 Homo sapiens Protein S100-A11 Proteins 0.000 description 12
101000781981 Homo sapiens Protein Wnt-11 Proteins 0.000 description 12
101000864786 Homo sapiens Secreted frizzled-related protein 2 Proteins 0.000 description 12
101000577877 Homo sapiens Stromelysin-3 Proteins 0.000 description 12
101000753253 Homo sapiens Tyrosine-protein kinase receptor Tie-1 Proteins 0.000 description 12
108091058560 IL8 Proteins 0.000 description 12
102100039065 Interleukin-1 beta Human genes 0.000 description 12
102100035017 Interleukin-18-binding protein Human genes 0.000 description 12
102100040704 Low-density lipoprotein receptor-related protein 6 Human genes 0.000 description 12
102100027998 Macrophage metalloelastase Human genes 0.000 description 12
102100030200 Matrix metalloproteinase-16 Human genes 0.000 description 12
102100026799 Matrix metalloproteinase-28 Human genes 0.000 description 12
102100029811 Protein S100-A11 Human genes 0.000 description 12
102100036567 Protein Wnt-11 Human genes 0.000 description 12
102100030054 Secreted frizzled-related protein 2 Human genes 0.000 description 12
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
102100028847 Stromelysin-3 Human genes 0.000 description 12
102100022007 Tyrosine-protein kinase receptor Tie-1 Human genes 0.000 description 12
101150045640 VWF gene Proteins 0.000 description 12
239000002299 complementary DNA Substances 0.000 description 12
239000012636 effector Substances 0.000 description 12
230000037361 pathway Effects 0.000 description 12
230000011514 reflex Effects 0.000 description 12
102100036537 von Willebrand factor Human genes 0.000 description 12
108060003951 Immunoglobulin Proteins 0.000 description 11
230000004071 biological effect Effects 0.000 description 11
210000000988 bone and bone Anatomy 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 11
239000012634 fragment Substances 0.000 description 11
102000018358 immunoglobulin Human genes 0.000 description 11
230000004054 inflammatory process Effects 0.000 description 11
239000003446 ligand Substances 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 11
239000002773 nucleotide Substances 0.000 description 11
238000004393 prognosis Methods 0.000 description 11
238000012549 training Methods 0.000 description 11
108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
108010028006 B-Cell Activating Factor Proteins 0.000 description 10
102000004127 Cytokines Human genes 0.000 description 10
108090000695 Cytokines Proteins 0.000 description 10
101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 10
101000934372 Homo sapiens Macrosialin Proteins 0.000 description 10
102100025136 Macrosialin Human genes 0.000 description 10
230000008236 biological pathway Effects 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
230000008569 process Effects 0.000 description 10
239000000243 solution Substances 0.000 description 10
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 9
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 9
108010021625 Immunoglobulin Fragments Proteins 0.000 description 9
102000008394 Immunoglobulin Fragments Human genes 0.000 description 9
206010061218 Inflammation Diseases 0.000 description 9
241000124008 Mammalia Species 0.000 description 9
230000008901 benefit Effects 0.000 description 9
238000001514 detection method Methods 0.000 description 9
229960000403 etanercept Drugs 0.000 description 9
210000002950 fibroblast Anatomy 0.000 description 9
238000009396 hybridization Methods 0.000 description 9
208000014674 injury Diseases 0.000 description 9
210000004698 lymphocyte Anatomy 0.000 description 9
108020004999 messenger RNA Proteins 0.000 description 9
201000008482 osteoarthritis Diseases 0.000 description 9
230000011664 signaling Effects 0.000 description 9
238000010186 staining Methods 0.000 description 9
206010002556 Ankylosing Spondylitis Diseases 0.000 description 8
102000016605 B-Cell Activating Factor Human genes 0.000 description 8
108020004414 DNA Proteins 0.000 description 8
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 8
208000027418 Wounds and injury Diseases 0.000 description 8
230000004913 activation Effects 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
230000000295 complement effect Effects 0.000 description 8
230000004540 complement-dependent cytotoxicity Effects 0.000 description 8
238000002405 diagnostic procedure Methods 0.000 description 8
210000002540 macrophage Anatomy 0.000 description 8
230000004048 modification Effects 0.000 description 8
238000012986 modification Methods 0.000 description 8
238000003199 nucleic acid amplification method Methods 0.000 description 8
230000001575 pathological effect Effects 0.000 description 8
238000003753 real-time PCR Methods 0.000 description 8
239000000758 substrate Substances 0.000 description 8
229960001940 sulfasalazine Drugs 0.000 description 8
NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 8
NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 8
230000004083 survival effect Effects 0.000 description 8
230000006044 T cell activation Effects 0.000 description 7
230000003321 amplification Effects 0.000 description 7
210000000170 cell membrane Anatomy 0.000 description 7
239000000306 component Substances 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
210000000811 metacarpophalangeal joint Anatomy 0.000 description 7
230000000750 progressive effect Effects 0.000 description 7
239000007787 solid Substances 0.000 description 7
210000001258 synovial membrane Anatomy 0.000 description 7
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 6
BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 6
108010008014 B-Cell Maturation Antigen Proteins 0.000 description 6
102000006942 B-Cell Maturation Antigen Human genes 0.000 description 6
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 6
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 6
101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 description 6
102000013691 Interleukin-17 Human genes 0.000 description 6
108050003558 Interleukin-17 Proteins 0.000 description 6
102000004889 Interleukin-6 Human genes 0.000 description 6
108090001005 Interleukin-6 Proteins 0.000 description 6
241000699666 Mus <mouse, genus> Species 0.000 description 6
108091034117 Oligonucleotide Proteins 0.000 description 6
108700002718 TACI receptor-IgG Fc fragment fusion Proteins 0.000 description 6
102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 6
229960002964 adalimumab Drugs 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
230000001684 chronic effect Effects 0.000 description 6
230000007423 decrease Effects 0.000 description 6
208000035475 disorder Diseases 0.000 description 6
238000005516 engineering process Methods 0.000 description 6
238000011156 evaluation Methods 0.000 description 6
238000000338 in vitro Methods 0.000 description 6
208000015181 infectious disease Diseases 0.000 description 6
230000002757 inflammatory effect Effects 0.000 description 6
230000007774 longterm Effects 0.000 description 6
238000005259 measurement Methods 0.000 description 6
210000000878 metatarsophalangeal joint Anatomy 0.000 description 6
201000006417 multiple sclerosis Diseases 0.000 description 6
210000002997 osteoclast Anatomy 0.000 description 6
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 6
239000008194 pharmaceutical composition Substances 0.000 description 6
238000002360 preparation method Methods 0.000 description 6
238000004062 sedimentation Methods 0.000 description 6
150000003384 small molecules Chemical class 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
235000000346 sugar Nutrition 0.000 description 6
229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 6
238000005406 washing Methods 0.000 description 6
210000000707 wrist Anatomy 0.000 description 6
RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 5
101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 5
108010073807 IgG Receptors Proteins 0.000 description 5
108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 5
201000001263 Psoriatic Arthritis Diseases 0.000 description 5
208000036824 Psoriatic arthropathy Diseases 0.000 description 5
239000004783 Serene Substances 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 5
229960002170 azathioprine Drugs 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
230000000903 blocking effect Effects 0.000 description 5
239000000872 buffer Substances 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
239000013068 control sample Substances 0.000 description 5
235000018417 cysteine Nutrition 0.000 description 5
125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 5
230000009266 disease activity Effects 0.000 description 5
210000003743 erythrocyte Anatomy 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
229960001743 golimumab Drugs 0.000 description 5
XXSMGPRMXLTPCZ-UHFFFAOYSA-N hydroxychloroquine Chemical compound ClC1=CC=C2C(NC(C)CCCN(CCO)CC)=CC=NC2=C1 XXSMGPRMXLTPCZ-UHFFFAOYSA-N 0.000 description 5
229960001001 ibritumomab tiuxetan Drugs 0.000 description 5
230000001976 improved effect Effects 0.000 description 5
239000003112 inhibitor Substances 0.000 description 5
229960000681 leflunomide Drugs 0.000 description 5
VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 5
230000007246 mechanism Effects 0.000 description 5
230000001404 mediated effect Effects 0.000 description 5
238000002483 medication Methods 0.000 description 5
239000012528 membrane Substances 0.000 description 5
210000004180 plasmocyte Anatomy 0.000 description 5
230000001737 promoting effect Effects 0.000 description 5
230000004043 responsiveness Effects 0.000 description 5
238000012552 review Methods 0.000 description 5
MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 5
239000001509 sodium citrate Substances 0.000 description 5
241000894007 species Species 0.000 description 5
238000007619 statistical method Methods 0.000 description 5
239000000126 substance Substances 0.000 description 5
230000009885 systemic effect Effects 0.000 description 5
201000000596 systemic lupus erythematosus Diseases 0.000 description 5
238000012800 visualization Methods 0.000 description 5
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
102000004190 Enzymes Human genes 0.000 description 4
108090000790 Enzymes Proteins 0.000 description 4
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 4
101000896557 Homo sapiens Eukaryotic translation initiation factor 3 subunit B Proteins 0.000 description 4
101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 4
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 4
102000000589 Interleukin-1 Human genes 0.000 description 4
108010002352 Interleukin-1 Proteins 0.000 description 4
206010023203 Joint destruction Diseases 0.000 description 4
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 4
241000699670 Mus sp. Species 0.000 description 4
206010028980 Neoplasm Diseases 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
208000002193 Pain Diseases 0.000 description 4
208000025747 Rheumatic disease Diseases 0.000 description 4
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 4
241000251539 Vertebrata <Metazoa> Species 0.000 description 4
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
125000000539 amino acid group Chemical group 0.000 description 4
150000001413 amino acids Chemical class 0.000 description 4
210000000612 antigen-presenting cell Anatomy 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004899 c-terminal region Anatomy 0.000 description 4
238000012512 characterization method Methods 0.000 description 4
230000016396 cytokine production Effects 0.000 description 4
230000001086 cytosolic effect Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
239000002988 disease modifying antirheumatic drug Substances 0.000 description 4
229940073621 enbrel Drugs 0.000 description 4
229940088598 enzyme Drugs 0.000 description 4
230000036541 health Effects 0.000 description 4
230000002055 immunohistochemical effect Effects 0.000 description 4
230000008595 infiltration Effects 0.000 description 4
238000001764 infiltration Methods 0.000 description 4
230000002401 inhibitory effect Effects 0.000 description 4
230000005764 inhibitory process Effects 0.000 description 4
230000003993 interaction Effects 0.000 description 4
230000003902 lesion Effects 0.000 description 4
238000007403 mPCR Methods 0.000 description 4
238000010208 microarray analysis Methods 0.000 description 4
230000035772 mutation Effects 0.000 description 4
210000000963 osteoblast Anatomy 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
230000001991 pathophysiological effect Effects 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
230000009467 reduction Effects 0.000 description 4
238000012216 screening Methods 0.000 description 4
230000028327 secretion Effects 0.000 description 4
230000035945 sensitivity Effects 0.000 description 4
238000010206 sensitivity analysis Methods 0.000 description 4
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
229960005267 tositumomab Drugs 0.000 description 4
239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 4
102000003298 tumor necrosis factor receptor Human genes 0.000 description 4
230000003844 B-cell-activation Effects 0.000 description 3
102000004506 Blood Proteins Human genes 0.000 description 3
108010017384 Blood Proteins Proteins 0.000 description 3
102000014914 Carrier Proteins Human genes 0.000 description 3
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
108010036949 Cyclosporine Proteins 0.000 description 3
208000016192 Demyelinating disease Diseases 0.000 description 3
206010012305 Demyelination Diseases 0.000 description 3
102000001477 Deubiquitinating Enzymes Human genes 0.000 description 3
108010093668 Deubiquitinating Enzymes Proteins 0.000 description 3
229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 3
108700039887 Essential Genes Proteins 0.000 description 3
206010019280 Heart failures Diseases 0.000 description 3
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 3
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 3
102100020881 Interleukin-1 alpha Human genes 0.000 description 3
102000004310 Ion Channels Human genes 0.000 description 3
108090000862 Ion Channels Proteins 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
108010052285 Membrane Proteins Proteins 0.000 description 3
102000018697 Membrane Proteins Human genes 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
206010057249 Phagocytosis Diseases 0.000 description 3
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
108091000080 Phosphotransferase Proteins 0.000 description 3
208000009921 Rheumatoid Nodule Diseases 0.000 description 3
108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 description 3
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
238000000692 Student's t-test Methods 0.000 description 3
101150033527 TNF gene Proteins 0.000 description 3
102100040247 Tumor necrosis factor Human genes 0.000 description 3
102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 3
102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 3
108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
108091008324 binding proteins Proteins 0.000 description 3
230000031018 biological processes and functions Effects 0.000 description 3
230000033228 biological regulation Effects 0.000 description 3
238000001574 biopsy Methods 0.000 description 3
238000010804 cDNA synthesis Methods 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
230000030833 cell death Effects 0.000 description 3
230000011748 cell maturation Effects 0.000 description 3
239000002458 cell surface marker Substances 0.000 description 3
229960001265 ciclosporin Drugs 0.000 description 3
229940090100 cimzia Drugs 0.000 description 3
230000024203 complement activation Effects 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
238000002790 cross-validation Methods 0.000 description 3
231100000433 cytotoxic Toxicity 0.000 description 3
230000001472 cytotoxic effect Effects 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
230000003628 erosive effect Effects 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
210000004247 hand Anatomy 0.000 description 3
102000057041 human TNF Human genes 0.000 description 3
229940048921 humira Drugs 0.000 description 3
210000004408 hybridoma Anatomy 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
230000016784 immunoglobulin production Effects 0.000 description 3
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
230000006698 induction Effects 0.000 description 3
108091008042 inhibitory receptors Proteins 0.000 description 3
238000007918 intramuscular administration Methods 0.000 description 3
238000011068 loading method Methods 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
150000002739 metals Chemical class 0.000 description 3
210000000822 natural killer cell Anatomy 0.000 description 3
230000021766 negative regulation of B cell proliferation Effects 0.000 description 3
108010068617 neonatal Fc receptor Proteins 0.000 description 3
210000000440 neutrophil Anatomy 0.000 description 3
229950005751 ocrelizumab Drugs 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
230000008520 organization Effects 0.000 description 3
230000008506 pathogenesis Effects 0.000 description 3
230000008782 phagocytosis Effects 0.000 description 3
102000020233 phosphotransferase Human genes 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000012545 processing Methods 0.000 description 3
230000000069 prophylactic effect Effects 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000010188 recombinant method Methods 0.000 description 3
239000013074 reference sample Substances 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
229940116176 remicade Drugs 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
238000013077 scoring method Methods 0.000 description 3
238000011272 standard treatment Methods 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
238000012353 t test Methods 0.000 description 3
230000008685 targeting Effects 0.000 description 3
238000011285 therapeutic regimen Methods 0.000 description 3
231100000331 toxic Toxicity 0.000 description 3
230000002588 toxic effect Effects 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
201000008827 tuberculosis Diseases 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000972773 Aulopiformes Species 0.000 description 2
108091008875 B cell receptors Proteins 0.000 description 2
206010051728 Bone erosion Diseases 0.000 description 2
206010065687 Bone loss Diseases 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
101150013553 CD40 gene Proteins 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
102000019034 Chemokines Human genes 0.000 description 2
108010012236 Chemokines Proteins 0.000 description 2
102100032768 Complement receptor type 2 Human genes 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
VVNCNSJFMMFHPL-VKHMYHEASA-N D-penicillamine Chemical compound CC(C)(S)[C@@H](N)C(O)=O VVNCNSJFMMFHPL-VKHMYHEASA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
238000012286 ELISA Assay Methods 0.000 description 2
238000008157 ELISA kit Methods 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
108010021468 Fc gamma receptor IIA Proteins 0.000 description 2
108010021472 Fc gamma receptor IIB Proteins 0.000 description 2
229930186217 Glycolipid Natural products 0.000 description 2
108090000288 Glycoproteins Proteins 0.000 description 2
102000003886 Glycoproteins Human genes 0.000 description 2
101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 2
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 2
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 2
206010020751 Hypersensitivity Diseases 0.000 description 2
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 description 2
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
102100020880 Kit ligand Human genes 0.000 description 2
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 2
102100029205 Low affinity immunoglobulin gamma Fc region receptor II-b Human genes 0.000 description 2
102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
108700018351 Major Histocompatibility Complex Proteins 0.000 description 2
108010090054 Membrane Glycoproteins Proteins 0.000 description 2
102000012750 Membrane Glycoproteins Human genes 0.000 description 2
BLXXJMDCKKHMKV-UHFFFAOYSA-N Nabumetone Chemical compound C1=C(CCC(C)=O)C=CC2=CC(OC)=CC=C21 BLXXJMDCKKHMKV-UHFFFAOYSA-N 0.000 description 2
101710163270 Nuclease Proteins 0.000 description 2
108020004711 Nucleic Acid Probes Proteins 0.000 description 2
108010035042 Osteoprotegerin Proteins 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
241000288906 Primates Species 0.000 description 2
108010025832 RANK Ligand Proteins 0.000 description 2
102000014128 RANK Ligand Human genes 0.000 description 2
238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
241000700159 Rattus Species 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
208000021386 Sjogren Syndrome Diseases 0.000 description 2
108010088160 Staphylococcal Protein A Proteins 0.000 description 2
108010039445 Stem Cell Factor Proteins 0.000 description 2
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 2
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 2
239000007984 Tris EDTA buffer Substances 0.000 description 2
101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 2
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
206010054094 Tumour necrosis Diseases 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
229960001138 acetylsalicylic acid Drugs 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
230000001154 acute effect Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
238000000540 analysis of variance Methods 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
238000003782 apoptosis assay Methods 0.000 description 2
210000001188 articular cartilage Anatomy 0.000 description 2
210000000544 articulatio talocruralis Anatomy 0.000 description 2
208000006673 asthma Diseases 0.000 description 2
229950009925 atacicept Drugs 0.000 description 2
208000037979 autoimmune inflammatory disease Diseases 0.000 description 2
230000002146 bilateral effect Effects 0.000 description 2
238000009534 blood test Methods 0.000 description 2
238000010805 cDNA synthesis kit Methods 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000004663 cell proliferation Effects 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
208000037976 chronic inflammation Diseases 0.000 description 2
238000013145 classification model Methods 0.000 description 2
230000007012 clinical effect Effects 0.000 description 2
238000004891 communication Methods 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
230000004940 costimulation Effects 0.000 description 2
230000000139 costimulatory effect Effects 0.000 description 2
229960004397 cyclophosphamide Drugs 0.000 description 2
229930182912 cyclosporin Natural products 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
231100000599 cytotoxic agent Toxicity 0.000 description 2
230000034994 death Effects 0.000 description 2
238000005115 demineralization Methods 0.000 description 2
230000002328 demineralizing effect Effects 0.000 description 2
230000000779 depleting effect Effects 0.000 description 2
229960000633 dextran sulfate Drugs 0.000 description 2
230000009274 differential gene expression Effects 0.000 description 2
238000009826 distribution Methods 0.000 description 2
230000003828 downregulation Effects 0.000 description 2
210000002310 elbow joint Anatomy 0.000 description 2
230000005713 exacerbation Effects 0.000 description 2
238000010195 expression analysis Methods 0.000 description 2
210000003414 extremity Anatomy 0.000 description 2
206010016256 fatigue Diseases 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000003325 follicular Effects 0.000 description 2
238000009472 formulation Methods 0.000 description 2
238000013467 fragmentation Methods 0.000 description 2
238000006062 fragmentation reaction Methods 0.000 description 2
238000003633 gene expression assay Methods 0.000 description 2
238000011223 gene expression profiling Methods 0.000 description 2
230000009368 gene silencing by RNA Effects 0.000 description 2
239000011521 glass Substances 0.000 description 2
150000002343 gold Chemical class 0.000 description 2
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
239000010931 gold Substances 0.000 description 2
229910052737 gold Inorganic materials 0.000 description 2
230000012010 growth Effects 0.000 description 2
102000044132 human CXCL13 Human genes 0.000 description 2
230000008348 humoral response Effects 0.000 description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
229960004171 hydroxychloroquine Drugs 0.000 description 2
206010020718 hyperplasia Diseases 0.000 description 2
230000028993 immune response Effects 0.000 description 2
230000036039 immunity Effects 0.000 description 2
229940072221 immunoglobulins Drugs 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
210000000629 knee joint Anatomy 0.000 description 2
238000002372 labelling Methods 0.000 description 2
125000005647 linker group Chemical group 0.000 description 2
210000004324 lymphatic system Anatomy 0.000 description 2
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
239000000463 material Substances 0.000 description 2
210000003519 mature b lymphocyte Anatomy 0.000 description 2
DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 2
229960004023 minocycline Drugs 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
210000001616 monocyte Anatomy 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 2
229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
239000002853 nucleic acid probe Substances 0.000 description 2
XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000007170 pathology Effects 0.000 description 2
229960001639 penicillamine Drugs 0.000 description 2
238000002823 phage display Methods 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
239000002243 precursor Substances 0.000 description 2
OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 2
229960005205 prednisolone Drugs 0.000 description 2
230000002265 prevention Effects 0.000 description 2
230000000770 proinflammatory effect Effects 0.000 description 2
125000006239 protecting group Chemical group 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
238000000746 purification Methods 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
230000008439 repair process Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
230000019254 respiratory burst Effects 0.000 description 2
235000019515 salmon Nutrition 0.000 description 2
229940068638 simponi Drugs 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 2
230000008961 swelling Effects 0.000 description 2
238000010189 synthetic method Methods 0.000 description 2
230000009897 systematic effect Effects 0.000 description 2
UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 2
238000011830 transgenic mouse model Methods 0.000 description 2
238000013519 translation Methods 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
239000002451 tumor necrosis factor inhibitor Substances 0.000 description 2
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
238000010200 validation analysis Methods 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
210000003857 wrist joint Anatomy 0.000 description 2
HMLGSIZOMSVISS-ONJSNURVSA-N (7r)-7-[[(2z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound N([C@@H]1C(N2C(=C(C=C)CSC21)C(O)=O)=O)C(=O)\C(=N/OCOC(=O)C(C)(C)C)C1=CSC(N)=N1 HMLGSIZOMSVISS-ONJSNURVSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 1
HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 1
UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 1
HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
102100022464 5'-nucleotidase Human genes 0.000 description 1
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 1
108010075348 Activated-Leukocyte Cell Adhesion Molecule Proteins 0.000 description 1
102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 1
108091093088 Amplicon Proteins 0.000 description 1
108090000672 Annexin A5 Proteins 0.000 description 1
102000004121 Annexin A5 Human genes 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
108010046304 B-Cell Activation Factor Receptor Proteins 0.000 description 1
102000019260 B-Cell Antigen Receptors Human genes 0.000 description 1
108010012919 B-Cell Antigen Receptors Proteins 0.000 description 1
102100025218 B-cell differentiation antigen CD72 Human genes 0.000 description 1
101710187595 B-cell receptor CD22 Proteins 0.000 description 1
PCLCDPVEEFVAAQ-UHFFFAOYSA-N BCA 1 Chemical compound CC(CO)CCCC(C)C1=CCC(C)(O)C1CC2=C(O)C(O)CCC2=O PCLCDPVEEFVAAQ-UHFFFAOYSA-N 0.000 description 1
102100029945 Beta-galactoside alpha-2,6-sialyltransferase 1 Human genes 0.000 description 1
208000020084 Bone disease Diseases 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
102100025074 C-C chemokine receptor-like 2 Human genes 0.000 description 1
102100031658 C-X-C chemokine receptor type 5 Human genes 0.000 description 1
102100032528 C-type lectin domain family 11 member A Human genes 0.000 description 1
102100040841 C-type lectin domain family 5 member A Human genes 0.000 description 1
102100040840 C-type lectin domain family 7 member A Human genes 0.000 description 1
102100024210 CD166 antigen Human genes 0.000 description 1
102100027221 CD81 antigen Human genes 0.000 description 1
102100027217 CD82 antigen Human genes 0.000 description 1
102100035793 CD83 antigen Human genes 0.000 description 1
108010021064 CTLA-4 Antigen Proteins 0.000 description 1
229940045513 CTLA4 antagonist Drugs 0.000 description 1
102100024155 Cadherin-11 Human genes 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
208000000094 Chronic Pain Diseases 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
102000000503 Collagen Type II Human genes 0.000 description 1
108010041390 Collagen Type II Proteins 0.000 description 1
241000759568 Corixa Species 0.000 description 1
208000011231 Crohn disease Diseases 0.000 description 1
229930105110 Cyclosporin A Natural products 0.000 description 1
102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 description 1
101710112752 Cytotoxin Proteins 0.000 description 1
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
101100239628 Danio rerio myca gene Proteins 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
206010061819 Disease recurrence Diseases 0.000 description 1
206010014733 Endometrial cancer Diseases 0.000 description 1
206010014759 Endometrial neoplasm Diseases 0.000 description 1
101150117357 F2 gene Proteins 0.000 description 1
101150064015 FAS gene Proteins 0.000 description 1
102100031517 Fc receptor-like protein 1 Human genes 0.000 description 1
101710120224 Fc receptor-like protein 1 Proteins 0.000 description 1
102100031511 Fc receptor-like protein 2 Human genes 0.000 description 1
102100031512 Fc receptor-like protein 3 Human genes 0.000 description 1
102100031513 Fc receptor-like protein 4 Human genes 0.000 description 1
102100031508 Fc receptor-like protein 6 Human genes 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
206010016717 Fistula Diseases 0.000 description 1
206010017533 Fungal infection Diseases 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
102000002068 Glycopeptides Human genes 0.000 description 1
108010015899 Glycopeptides Proteins 0.000 description 1
102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
102100031546 HLA class II histocompatibility antigen, DO beta chain Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 description 1
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 1
101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 1
101000934359 Homo sapiens B-cell differentiation antigen CD72 Proteins 0.000 description 1
101000863864 Homo sapiens Beta-galactoside alpha-2,6-sialyltransferase 1 Proteins 0.000 description 1
101000716068 Homo sapiens C-C chemokine receptor type 6 Proteins 0.000 description 1
101000922405 Homo sapiens C-X-C chemokine receptor type 5 Proteins 0.000 description 1
101000942297 Homo sapiens C-type lectin domain family 11 member A Proteins 0.000 description 1
101000749314 Homo sapiens C-type lectin domain family 5 member A Proteins 0.000 description 1
101000749325 Homo sapiens C-type lectin domain family 7 member A Proteins 0.000 description 1
101000914479 Homo sapiens CD81 antigen Proteins 0.000 description 1
101000914469 Homo sapiens CD82 antigen Proteins 0.000 description 1
101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 1
101100275686 Homo sapiens CR2 gene Proteins 0.000 description 1
101000762236 Homo sapiens Cadherin-11 Proteins 0.000 description 1
101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 description 1
101000846911 Homo sapiens Fc receptor-like protein 2 Proteins 0.000 description 1
101000846910 Homo sapiens Fc receptor-like protein 3 Proteins 0.000 description 1
101000846909 Homo sapiens Fc receptor-like protein 4 Proteins 0.000 description 1
101000846906 Homo sapiens Fc receptor-like protein 6 Proteins 0.000 description 1
101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
101000866281 Homo sapiens HLA class II histocompatibility antigen, DO beta chain Proteins 0.000 description 1
101000960952 Homo sapiens Interleukin-1 receptor accessory protein Proteins 0.000 description 1
101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
101000852483 Homo sapiens Interleukin-1 receptor-associated kinase 1 Proteins 0.000 description 1
101001019602 Homo sapiens Interleukin-17 receptor C Proteins 0.000 description 1
101001017833 Homo sapiens Leucine-rich repeat-containing protein 4 Proteins 0.000 description 1
101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 description 1
101000984196 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily A member 5 Proteins 0.000 description 1
101000984190 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 1 Proteins 0.000 description 1
101000980823 Homo sapiens Leukocyte surface antigen CD53 Proteins 0.000 description 1
101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 1
101000795107 Homo sapiens Triggering receptor expressed on myeloid cells 1 Proteins 0.000 description 1
101000847952 Homo sapiens Trypsin-3 Proteins 0.000 description 1
101000851434 Homo sapiens Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 1
101000798130 Homo sapiens Tumor necrosis factor receptor superfamily member 11B Proteins 0.000 description 1
101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
206010020880 Hypertrophy Diseases 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
102100034343 Integrase Human genes 0.000 description 1
229940119178 Interleukin 1 receptor antagonist Drugs 0.000 description 1
102100039880 Interleukin-1 receptor accessory protein Human genes 0.000 description 1
108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
102100036342 Interleukin-1 receptor-associated kinase 1 Human genes 0.000 description 1
102000003814 Interleukin-10 Human genes 0.000 description 1
108090000174 Interleukin-10 Proteins 0.000 description 1
108090000177 Interleukin-11 Proteins 0.000 description 1
102000003815 Interleukin-11 Human genes 0.000 description 1
102000013462 Interleukin-12 Human genes 0.000 description 1
108010065805 Interleukin-12 Proteins 0.000 description 1
102100020790 Interleukin-12 receptor subunit beta-1 Human genes 0.000 description 1
101710103841 Interleukin-12 receptor subunit beta-1 Proteins 0.000 description 1
102100020792 Interleukin-12 receptor subunit beta-2 Human genes 0.000 description 1
101710103840 Interleukin-12 receptor subunit beta-2 Proteins 0.000 description 1
102100035012 Interleukin-17 receptor C Human genes 0.000 description 1
108010002350 Interleukin-2 Proteins 0.000 description 1
108010017411 Interleukin-21 Receptors Proteins 0.000 description 1
102100030699 Interleukin-21 receptor Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
108010002586 Interleukin-7 Proteins 0.000 description 1
108010002335 Interleukin-9 Proteins 0.000 description 1
102000000585 Interleukin-9 Human genes 0.000 description 1
206010023232 Joint swelling Diseases 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
102100033304 Leucine-rich repeat-containing protein 4 Human genes 0.000 description 1
102100031586 Leukocyte antigen CD37 Human genes 0.000 description 1
102100025574 Leukocyte immunoglobulin-like receptor subfamily A member 5 Human genes 0.000 description 1
102100024221 Leukocyte surface antigen CD53 Human genes 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
102000008072 Lymphokines Human genes 0.000 description 1
108010074338 Lymphokines Proteins 0.000 description 1
101150033052 MAS5 gene Proteins 0.000 description 1
102000013967 Monokines Human genes 0.000 description 1
108010050619 Monokines Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
101100327295 Mus musculus Cd22 gene Proteins 0.000 description 1
101100275687 Mus musculus Cr2 gene Proteins 0.000 description 1
101000846907 Mus musculus Fc receptor-like protein 5 Proteins 0.000 description 1
208000031888 Mycoses Diseases 0.000 description 1
CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
108090000028 Neprilysin Proteins 0.000 description 1
102000003729 Neprilysin Human genes 0.000 description 1
208000012902 Nervous system disease Diseases 0.000 description 1
108090000770 Neuropilin-2 Proteins 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000003076 Osteolysis Diseases 0.000 description 1
101710160107 Outer membrane protein A Proteins 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
208000012868 Overgrowth Diseases 0.000 description 1
102100037603 P2X purinoceptor 5 Human genes 0.000 description 1
101710189969 P2X purinoceptor 5 Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
241001111421 Pannus Species 0.000 description 1
108090000526 Papain Proteins 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical group [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 description 1
108010067787 Proteoglycans Proteins 0.000 description 1
102000016611 Proteoglycans Human genes 0.000 description 1
108091008103 RNA aptamers Proteins 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
208000035977 Rare disease Diseases 0.000 description 1
238000012952 Resampling Methods 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
101100344462 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YDJ1 gene Proteins 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
241000270295 Serpentes Species 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
101710137500 T7 RNA polymerase Proteins 0.000 description 1
101150084279 TM gene Proteins 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
108020004566 Transfer RNA Proteins 0.000 description 1
102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 1
102100029681 Triggering receptor expressed on myeloid cells 1 Human genes 0.000 description 1
102100034396 Trypsin-3 Human genes 0.000 description 1
102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 1
108091005966 Type III transmembrane proteins Proteins 0.000 description 1
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
206010047115 Vasculitis Diseases 0.000 description 1
102000013814 Wnt Human genes 0.000 description 1
108050003627 Wnt Proteins 0.000 description 1
238000002441 X-ray diffraction Methods 0.000 description 1
229960003697 abatacept Drugs 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
239000013543 active substance Substances 0.000 description 1
125000002015 acyclic group Chemical group 0.000 description 1
230000009824 affinity maturation Effects 0.000 description 1
238000005054 agglomeration Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
125000003342 alkenyl group Chemical group 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229940100198 alkylating agent Drugs 0.000 description 1
239000002168 alkylating agent Substances 0.000 description 1
230000007815 allergy Effects 0.000 description 1
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
229940059260 amidate Drugs 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
229960004238 anakinra Drugs 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000003092 anti-cytokine Effects 0.000 description 1
230000001064 anti-interferon Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
230000030741 antigen processing and presentation Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000003435 antirheumatic agent Substances 0.000 description 1
230000001640 apoptogenic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
238000003491 array Methods 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
230000002238 attenuated effect Effects 0.000 description 1
230000006472 autoimmune response Effects 0.000 description 1
230000005784 autoimmunity Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
230000008827 biological function Effects 0.000 description 1
239000000091 biomarker candidate Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
102000043871 biotin binding protein Human genes 0.000 description 1
108700021042 biotin binding protein Proteins 0.000 description 1
239000012503 blood component Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
230000037182 bone density Effects 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
230000010072 bone remodeling Effects 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
210000001175 cerebrospinal fluid Anatomy 0.000 description 1
229960003115 certolizumab pegol Drugs 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
230000006020 chronic inflammation Effects 0.000 description 1
208000037893 chronic inflammatory disorder Diseases 0.000 description 1
108010072917 class-I restricted T cell-associated molecule Proteins 0.000 description 1
238000003759 clinical diagnosis Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
238000011284 combination treatment Methods 0.000 description 1
230000004154 complement system Effects 0.000 description 1
239000002131 composite material Substances 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
210000002808 connective tissue Anatomy 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000008602 contraction Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000001054 cortical effect Effects 0.000 description 1
239000003246 corticosteroid Substances 0.000 description 1
229960001334 corticosteroids Drugs 0.000 description 1
101150070926 ct gene Proteins 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
108010061103 cyclic citrullinated peptide Proteins 0.000 description 1
125000000392 cycloalkenyl group Chemical group 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
239000002254 cytotoxic agent Substances 0.000 description 1
239000002619 cytotoxin Substances 0.000 description 1
238000007405 data analysis Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000002939 deleterious effect Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
238000012631 diagnostic technique Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002472 endoplasmic reticulum Anatomy 0.000 description 1
229950009760 epratuzumab Drugs 0.000 description 1
NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
230000003890 fistula Effects 0.000 description 1
239000000834 fixative Substances 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
210000002683 foot Anatomy 0.000 description 1
239000012520 frozen sample Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
238000010353 genetic engineering Methods 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
210000001280 germinal center Anatomy 0.000 description 1
239000003862 glucocorticoid Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
229940076085 gold Drugs 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
238000007417 hierarchical cluster analysis Methods 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
102000050326 human TNFSF13B Human genes 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000002519 immonomodulatory effect Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000007235 immunity generation Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
238000002991 immunohistochemical analysis Methods 0.000 description 1
238000003364 immunohistochemistry Methods 0.000 description 1
239000003018 immunosuppressive agent Substances 0.000 description 1
229940125721 immunosuppressive agent Drugs 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
229940089536 indocin Drugs 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
230000004941 influx Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000011221 initial treatment Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 1
229940076144 interleukin-10 Drugs 0.000 description 1
229940100601 interleukin-6 Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007919 intrasynovial administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
125000002346 iodo group Chemical group I* 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229950000128 lumiliximab Drugs 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011654 magnesium acetate Substances 0.000 description 1
235000011285 magnesium acetate Nutrition 0.000 description 1
229940069446 magnesium acetate Drugs 0.000 description 1
238000002595 magnetic resonance imaging Methods 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000036244 malformation Effects 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
210000003826 marginal zone b cell Anatomy 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
238000010197 meta-analysis Methods 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
238000012775 microarray technology Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000003990 molecular pathway Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
229940072709 motrin Drugs 0.000 description 1
229940126619 mouse monoclonal antibody Drugs 0.000 description 1
206010028537 myelofibrosis Diseases 0.000 description 1
229960004270 nabumetone Drugs 0.000 description 1
229940090008 naprosyn Drugs 0.000 description 1
229960002009 naproxen Drugs 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000012177 negative regulation of immune response Effects 0.000 description 1
230000002981 neuropathic effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
230000011164 ossification Effects 0.000 description 1
230000003349 osteoarthritic effect Effects 0.000 description 1
230000004072 osteoblast differentiation Effects 0.000 description 1
229940043515 other immunoglobulins in atc Drugs 0.000 description 1
229940075461 other therapeutic product in atc Drugs 0.000 description 1
201000003733 ovarian melanoma Diseases 0.000 description 1
230000002018 overexpression Effects 0.000 description 1
230000001590 oxidative effect Effects 0.000 description 1
229940055729 papain Drugs 0.000 description 1
235000019834 papain Nutrition 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
238000001558 permutation test Methods 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
230000002688 persistence Effects 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000008177 pharmaceutical agent Substances 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
150000004713 phosphodiesters Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical group 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
208000005987 polymyositis Diseases 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
108091005626 post-translationally modified proteins Proteins 0.000 description 1
102000035123 post-translationally modified proteins Human genes 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
235000011056 potassium acetate Nutrition 0.000 description 1
229960004618 prednisone Drugs 0.000 description 1
XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
210000001948 pro-b lymphocyte Anatomy 0.000 description 1
230000005522 programmed cell death Effects 0.000 description 1
230000009145 protein modification Effects 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
230000005180 public health Effects 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
238000002708 random mutagenesis Methods 0.000 description 1
108700015048 receptor decoy activity proteins Proteins 0.000 description 1
238000011084 recovery Methods 0.000 description 1
229940087462 relafen Drugs 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
108020004418 ribosomal RNA Proteins 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
208000002491 severe combined immunodeficiency Diseases 0.000 description 1
230000009528 severe injury Effects 0.000 description 1
FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
229910000077 silane Inorganic materials 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
238000009097 single-agent therapy Methods 0.000 description 1
FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
229940048086 sodium pyrophosphate Drugs 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
230000008093 supporting effect Effects 0.000 description 1
230000001629 suppression Effects 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000008409 synovial inflammation Effects 0.000 description 1
210000002437 synoviocyte Anatomy 0.000 description 1
201000004595 synovitis Diseases 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
229960001017 tolmetin Drugs 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000009261 transgenic effect Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
230000008733 trauma Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
229940038773 trisodium citrate Drugs 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000005166 vasculature Anatomy 0.000 description 1
238000012795 verification Methods 0.000 description 1
230000007332 vesicle formation Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
150000003742 xyloses Chemical class 0.000 description 1

JP2012528063A 2009-09-03 2010-09-02 関節リウマチの治療、診断及びモニターするための方法 Active JP5996429B2 (ja)